Susquehanna International Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.93M Sell
1,822,600
-1,539,800
-46% -$8.64M ﹤0.01% 3131
2025
Q4
$23.5M Buy
3,362,400
+786,800
+31% +$6.16M ﹤0.01% 2040
2025
Q3
$19.9M Buy
2,575,600
+584,700
+29% +$4.56M ﹤0.01% 2213
2025
Q2
$17.3M Buy
1,990,900
+385,000
+24% +$2.79M ﹤0.01% 2158
2025
Q1
$12.8M Buy
1,605,900
+287,800
+22% +$2.91M ﹤0.01% 2224
2024
Q4
$12M Buy
1,318,100
+836,900
+174% +$8.08M ﹤0.01% 2435
2024
Q3
$4.42M Sell
481,200
-369,800
-43% -$3.06M ﹤0.01% 3802
2024
Q2
$8.32M Sell
851,000
-317,100
-27% -$3.87M ﹤0.01% 2730
2024
Q1
$17.6M Buy
1,168,100
+399,100
+52% +$7.24M ﹤0.01% 1921
2023
Q4
$16.6M Sell
769,000
-193,000
-20% -$3.56M ﹤0.01% 2003
2023
Q3
$17.9M Buy
962,000
+210,000
+28% +$4.9M ﹤0.01% 1862
2023
Q2
$19M Sell
752,000
-130,500
-15% -$3.28M ﹤0.01% 1768
2023
Q1
$22.9M Sell
882,500
-13,800
-2% -$369K ﹤0.01% 1573
2022
Q4
$21.2M Sell
896,300
-102,000
-10% -$2.75M 0.01% 1467
2022
Q3
$25.3M Sell
998,300
-1,003,700
-50% -$35.2M 0.01% 1220
2022
Q2
$66.5M Sell
2,002,000
-569,300
-22% -$24.2M 0.02% 698
2022
Q1
$185M Sell
2,571,300
-757,600
-23% -$54.6M 0.03% 418
2021
Q4
$306M Sell
3,328,900
-363,100
-10% -$43.4M 0.05% 338
2021
Q3
$468M Sell
3,692,000
-758,600
-17% -$110M 0.06% 251
2021
Q2
$740M Buy
4,450,600
+623,700
+16% +$101M 0.1% 146
2021
Q1
$696M Buy
3,826,900
+573,900
+18% +$133M 0.11% 140
2020
Q4
$650M Buy
3,253,000
+1,044,100
+47% +$212M 0.11% 134
2020
Q3
$484M Buy
2,208,900
+1,175,000
+114% +$249M 0.09% 157
2020
Q2
$197M Buy
1,033,900
+449,500
+77% +$78.8M 0.05% 304
2020
Q1
$90.6M Buy
584,400
+176,500
+43% +$20.5M 0.03% 421
2019
Q4
$34.1M Sell
407,900
-52,700
-11% -$4.01M 0.01% 1032
2019
Q3
$31.2M Buy
460,600
+124,200
+37% +$8.17M 0.01% 1012
2019
Q2
$22.3M Buy
336,400
+24,000
+8% +$1.4M 0.01% 1200
2019
Q1
$17.4M Buy
312,400
+68,700
+28% +$4.19M 0.01% 1293
2018
Q4
$12.1M Sell
243,700
-79,300
-25% -$4.85M ﹤0.01% 1435
2018
Q3
$27.9M Buy
323,000
+79,600
+33% +$5.67M 0.01% 1066
2018
Q2
$14.1M Buy
243,400
+59,900
+33% +$2.93M ﹤0.01% 1609
2018
Q1
$7.39M Sell
183,500
-171,000
-48% -$6.46M ﹤0.01% 2091
2017
Q4
$12.4M Buy
354,500
+263,700
+290% +$8.76M ﹤0.01% 1657
2017
Q3
$3.01M Sell
90,800
-34,400
-27% -$1.13M ﹤0.01% 3233
2017
Q2
$4.34M Buy
125,200
+14,000
+13% +$408K ﹤0.01% 2594
2017
Q1
$2.78M Buy
111,200
+40,700
+58% +$847K ﹤0.01% 3153
2016
Q4
$1.16M Sell
70,500
-2,200
-3% -$37.4K ﹤0.01% 5194
2016
Q3
$1.33M Buy
72,700
+31,200
+75% +$547K ﹤0.01% 4260
2016
Q2
$665K Buy
41,500
+6,700
+19% +$78.2K ﹤0.01% 5626
2016
Q1
$334K Sell
34,800
-100
-0.3% -$1.42K ﹤0.01% 7093
2015
Q4
$627K Buy
+34,900
New +$644K ﹤0.01% 6345

Other funds holding TDOC

Susquehanna International Group's TDOC Position: Q1 2026 in Review

Susquehanna International Group reduced its Teladoc Health (TDOC) stake by 17% in Q1 2026, selling an estimated $987K and leaving 885,526 shares worth $4.83M. The position accounts for ﹤0.01% of the portfolio, ranked #4299.

Susquehanna International Group first reported a position in TDOC in Q3 2016 and has held it in 36 quarters since. The position peaked at $241M in Q1 2021. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Susquehanna International Group held 885,526 shares of Teladoc Health worth $4.83M as of Q1 2026.
  • Susquehanna International Group sold 175,942 Teladoc Health shares in Q1 2026, an estimated $987K.
  • Teladoc Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4299 holding.
  • Susquehanna International Group first reported a position in Teladoc Health in Q3 2016 and has held it in 36 quarters since.
  • Susquehanna International Group's Teladoc Health position peaked at $241M in Q1 2021.
  • 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.